Drug giant to buy Sirtris for $720m

Sirtris Pharmaceuticals Inc., the Cambridge biotech company that has attracted national attention for trying to use drugs based on an extract in red wine to fight diabetes and other age-related diseases, is being sold to British pharmaceuticals giant GlaxoSmithKline PLC for $720 million, the companies said late yesterday. (Full article: 656 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

• $9.95 1 month archives pass
• $24.95 3 months archives pass
• $74.95 1 year archives pass